Risk assessment of components in tobacco smoke and e-cigarette aerosols: a pragmatic choice of dose metrics

Inhal Toxicol. 2021 Feb;33(3):81-95. doi: 10.1080/08958378.2021.1909678. Epub 2021 Apr 20.

Abstract

Background: Risk assessment of individual tobacco smoke components is important for the purpose of prioritization or selecting chemicals for monitoring products. Smoking is characterized by a highly varying, intermittent exposure and the challenge is to choose the most appropriate dose metric.

Methods: Generally, average daily exposure estimates are used as dose metric, without considering temporal determinants. The applicability hereof is discussed in the context of choosing dose metrics for local respiratory tract effects and for systemic effects in a smoking scenario or for the use of e-cigarettes.

Results: Using average daily exposure estimates for the smoking scenario can lead to erroneous risk evaluations for several reasons. Inhaled peak air concentrations during a puff can be two to three orders of magnitude higher than the calculated average daily inhaled concentration, which may impact the assessment of both systemic and local health effects. A pragmatic risk assessment is proposed, based on the Margin of Exposure (MoE) approach. The choice of an appropriate dose metric, such as inhaled concentration, inhaled dose or absorbed dose, depends on the type of effect. Temporal characteristics should be considered in the final step of the MoE approach, as is illustrated by two cases, glycerol and benzene.

Conclusion: The choice of an appropriate dose metric and inclusion of temporal determinants are important aspects in the risk assessment of individual smoke components. The proposed MoE approach provides the opportunity to weigh smoking-related exposure characteristics during the final step of the risk evaluation.

Keywords: Risk assessment; dosimetry; inhalation exposure; margin of exposure; tobacco smoke components.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aerosols / adverse effects
  • Aerosols / chemistry
  • Electronic Nicotine Delivery Systems*
  • Humans
  • Nicotiana / adverse effects
  • Nicotiana / chemistry*
  • Risk Assessment / methods*
  • Smoke / adverse effects
  • Smoke / analysis*

Substances

  • Aerosols
  • Smoke